Cellular senescence, chronic low-grade inflammation (inflammaging), and metabolic imbalance are key drivers of biological aging and age-related diseases. REAC® (Radio Electric Asymmetric Conveyer) technology represents an innovative, non-invasive solution that uses weak radioelectric fields conveyed asymmetrically to restore endogenous bioelectrical activity and promote cellular reprogramming. Over the past decade, several studies have demonstrated the efficacy of REAC® protocols in counteracting senescence and supporting tissue regeneration.
In vitro and clinical research has shown that REAC® biomodulation can modulate both telomerase-dependent and telomerase-independent pathways, reduce oxidative stress, enhance expression of anti-senescent and reparative genes, and improve microcirculation and metabolic efficiency. Specific REAC® protocols such as Anti-inflammatory Anti-Cellulite Treatment (ACT), Circulatory Optimization (CO), and Metabolic Optimization (MO) target the key biological mechanisms of aging, including chronic inflammation, vascular decline, and cellular energy deficits. These protocols have shown the ability to significantly delay senescence progression in stem cells and hematopoietic lineages, as well as improve clinical outcomes in degenerative and age-related conditions.
Supported by peer-reviewed publications in prestigious scientific journals including Scientific Reports, Age, Clinical Interventions in Aging, and Physiological Research, REAC® Technology represents a ready-to-use, safe, and effective therapeutic tool for anti-aging strategies and longevity-focused programs. Its reproducibility, ease of application, and broad spectrum of clinical indications make it particularly suitable for integration into specialized medical settings, wellness centers, and longevity-dedicated programs.
"Blue Zones" are areas of the world where longevity is the norm rather than the exception. Populations in Okinawa, Sardinia, Ikaria, and Nicoya share environmental, social, and biological traits that promote long and healthy lives. But what if it were possible to recreate these conditions within our own bodies, regardless of where we live?
The REAC® (Radio Electric Asymmetric Conveyer) Technology, through the ACT-IBZ, CO-IBZ, and MO-IBZ protocols, administrated by BENE Inside BlueZone medical device, offers a concrete answer. It is not about mimicking a lifestyle, but about actively modulating the cellular mechanisms that support health, prevent premature aging, and promote physiological longevity. The therapy is the unique medical treatment for longevity today, 100% effective, noninvasive, painless and safe, without any collateral effects.
Dr. Vania Fontani MD, PhD, is a prominent figure in the field of regenerative medicine and neurobiological modulation.
She has dedicated her career to research and the development of innovative technologies for human well-being.
Currently, Dr. Fontani holds the position of Scientific Director at the Rinaldi Fontani Institute in Florence, where she leads the Department of Regenerative Medicine.
In collaboration with Prof. Salvatore Rinaldi, she co-developed the REAC® (Radio Electric Asymmetric Conveyer) technology, a non-invasive methodology aimed at modulating endogenous bioelectric activity to promote health and well-being.
Her research work is documented in over 60 scientific publications, with a significant impact in the field of neuromodulation and regenerative medicine.
Her experience and expertise make her an ideal speaker for international events focused on innovation and longevity
Learn more:
• Publications: PubMed – Rinaldi S, Fontani V
Physician and researcher, pioneer in neurobiological modulation, regenerative medicine, and anti-senescence therapies Scientific Director – Rinaldi Fontani Institute, Florence, Italy
ORCID: 0000-0002-8961-6316
Profile and Mission
Salvatore Rinaldi is an internationally recognized innovator for his groundbreaking
contribution to the study and clinical application of neurobiological modulation using
asymmetrically conveyed radio-electric signals (REAC). His work has redefined the
boundaries of regenerative medicine and longevity, demonstrating how optimizing
endogenous bioelectrical activity can promote cellular reprogramming, recovery of
compromised functions, and the prevention of age-related decline.
Research Milestones
Rinaldi’s research has opened new frontiers in the understanding and treatment of
neurodegenerative diseases and cellular aging processes. Among his most significant
contributions:
Regenerative Medicine:
Anti-Senescence and Longevity:
Neurodegenerative Diseases – Efficacy of REAC Technology in Alzheimer’s and
Neurodegeneration Models:
Scientific Vision
Salvatore Rinaldi’s work demonstrates that bioelectrical modulation is not merely a
theoretical concept, but a concrete and reproducible therapeutic strategy to counteract
aging, support cellular repair processes, and prevent tissue degeneration.
Learn more:
• ORCID Profile: 0000-0002-8961-6316
• Publications: PubMed – Rinaldi S, Fontani V